RANIBIZUMAB - INTRAOCULAR

RANIBIZUMAB - INTRAOCULAR

PHONETIC PRONUNCIATION: (ra-ni-BIZ-oo-mab)

COMMON BRAND NAME(S): Lucentis

GENERIC NAME(S): ranibizumab

Uses

USES: This medication is used to treat certain serious eye conditions (such as age-related macular degeneration, macular edema, diabetic retinopathy). It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.


How to use RANIBIZUMAB - INTRAOCULAR

HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start receiving ranibizumab and each time you get a refill. If you have any questions, ask your doctor or pharmacist. This medication is given by injection into the affected eye(s) by a health care professional. The affected eye is numbed before each injection. Your eye will be monitored before the injection. After the injection, you will remain in the doctor's office for a while, and your eye will continue to be monitored. The dosage is based on your medical condition and response to treatment. This medication is given as directed by your doctor, usually once a month for most conditions. When treating age-related macular degeneration, if you are not able to have monthly injections after your first few doses, getting injections once every 2 or 3 months may be an option, although not as effective as monthly injections. Consult your doctor for more details. Use this medication regularly to get the most benefit from it. Tell your doctor if your condition does not improve or if it worsens.

Side Effects

SIDE EFFECTS: Mild discomfort and increased tears may occur in the affected eye(s). Feeling of spinning and dizziness may also occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. This medication may rarely increase your risk for developing a certain serious eye condition (endophthalmitis), especially during the first week after receiving a dose. Tell your doctor right away if you notice any of these symptoms in the affected eye(s): pain, redness, sensitivity to light, sudden change in vision. This medication may sometimes increase the risk of serious (possibly fatal) blood clots. This may lead to stroke, heart attack, and other blood vessel problems. Get medical help right away if you develop: symptoms of stroke (such as weakness on one side of the body, slurred speech, sudden vision changes, confusion), symptoms of a heart attack (such as chest/jaw/left arm pain). A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Precautions

PRECAUTIONS: Before receiving ranibizumab, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: a current eye infection, stroke. Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). This drug may make you dizzy or blur your vision. Alcohol or marijuana can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness or clear vision until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana. During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor. It is not known whether this drug passes into breast milk. However, this medication is unlikely to pass into breast milk. Consult your doctor before breast-feeding.

Interactions

DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.

Overdose

OVERDOSE: This medicine may be harmful if swallowed. If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

Reviews

No Reviews Yet


Faq for RANIBIZUMAB - INTRAOCULAR

Ranibizumab is a drug that is injected into the eye to treat various eye conditions such as wet age-related macular degeneration (AMD), macular edema, diabetic retinopathy, and macular edema following retinal vein occlusion.

Ranibizumab is an anti-vascular endothelial growth factor (VEGF) drug. It works by binding to and inhibiting VEGF, a protein that can cause abnormal blood vessel growth in the eye. By blocking VEGF, ranibizumab helps to reduce the growth and leakage of abnormal blood vessels, thereby improving vision.

The recommended dosing regimen for ranibizumab depends on the specific eye condition being treated. For most conditions, the initial treatment involves monthly injections for a certain period, followed by less frequent maintenance injections as determined by your doctor. However, your doctor will tailor the treatment plan to your individual needs.

The most common side effects of ranibizumab include eye pain, floaters, increased intraocular pressure, conjunctival hemorrhage, and blurred vision. Serious side effects such as infection or detachment of the retina are rare but possible. It is important to report any concerning symptoms to your doctor promptly.

The onset of ranibizumab's effects can vary depending on the individual and the eye condition being treated. Some patients may start noticing improvements in their vision within a few days or weeks after starting treatment, while for others it may take longer. Your doctor can provide more specific information based on your situation.

After receiving a ranibizumab injection, your eyes might be sensitive and your vision may be temporarily blurred. It is recommended to avoid driving until your vision has fully recovered, which usually occurs within a day or two after the injection. It is best to arrange for someone else to drive you home after the procedure.



Disclaimer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.